Massachusetts Financial Services Co. MA Trims Stock Holdings in Zoetis Inc. $ZTS

Massachusetts Financial Services Co. MA cut its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 95.7% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 18,655 shares of the company’s stock after selling 416,742 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Zoetis were worth $1,341,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. RFG Advisory LLC grew its position in shares of Zoetis by 4.9% during the fourth quarter. RFG Advisory LLC now owns 1,708 shares of the company’s stock worth $215,000 after buying an additional 80 shares in the last quarter. Quest 10 Wealth Builders Inc. raised its holdings in Zoetis by 4.7% in the fourth quarter. Quest 10 Wealth Builders Inc. now owns 1,904 shares of the company’s stock valued at $240,000 after acquiring an additional 86 shares in the last quarter. Financial Engines Advisors L.L.C. raised its holdings in Zoetis by 4.4% in the third quarter. Financial Engines Advisors L.L.C. now owns 2,043 shares of the company’s stock valued at $299,000 after acquiring an additional 87 shares in the last quarter. Physician Wealth Advisors Inc. boosted its stake in Zoetis by 17.4% during the 1st quarter. Physician Wealth Advisors Inc. now owns 615 shares of the company’s stock valued at $73,000 after acquiring an additional 91 shares during the last quarter. Finally, Smithfield Trust Co grew its holdings in Zoetis by 4.2% during the 4th quarter. Smithfield Trust Co now owns 2,294 shares of the company’s stock worth $290,000 after acquiring an additional 92 shares in the last quarter. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the stock. Weiss Ratings downgraded shares of Zoetis from a “sell (d+)” rating to a “sell (d)” rating in a research report on Friday, June 12th. BNP Paribas Exane decreased their price target on Zoetis from $146.00 to $110.00 and set an “outperform” rating for the company in a research note on Tuesday. Argus reissued a “hold” rating on shares of Zoetis in a report on Wednesday, May 27th. TD Cowen reduced their target price on Zoetis from $150.00 to $104.00 and set a “buy” rating on the stock in a report on Tuesday, June 30th. Finally, Citigroup decreased their target price on Zoetis from $112.00 to $96.00 and set a “buy” rating for the company in a research report on Tuesday. Eight analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, Zoetis currently has an average rating of “Hold” and a consensus price target of $109.62.

Zoetis Price Performance

Shares of NYSE:ZTS opened at $73.64 on Friday. The company has a quick ratio of 1.84, a current ratio of 3.08 and a debt-to-equity ratio of 2.87. Zoetis Inc. has a fifty-two week low of $71.45 and a fifty-two week high of $160.48. The firm has a 50-day simple moving average of $76.30 and a 200 day simple moving average of $99.01. The company has a market cap of $30.43 billion, a PE ratio of 12.13, a P/E/G ratio of 1.31 and a beta of 0.74.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, August 6th. The company reported $1.87 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.02. Zoetis had a net margin of 27.49% and a return on equity of 74.89%. The firm had revenue of $2.47 billion for the quarter, compared to analyst estimates of $2.50 billion. During the same quarter in the prior year, the business earned $1.76 earnings per share. Zoetis’s quarterly revenue was down .2% on a year-over-year basis. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. On average, sell-side analysts anticipate that Zoetis Inc. will post 6.19 EPS for the current year.

Zoetis Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Stockholders of record on Monday, July 20th will be given a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Monday, July 20th. Zoetis’s dividend payout ratio is presently 34.93%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.